期刊文献+

人源化抗人肺癌单域抗体基因的构建、表达及活性分析 被引量:5

Gene’s construction, expression and activity analysis of humanized single-domain antibody against human lung cancer
原文传递
导出
摘要 目的:构建人源化的抗人肺癌单域抗体hu3D3VH基因,在大肠杆菌中表达,对其蛋白活性进行分析。方法:采用CDR移植技术对mAb3D3的重链可变区进行人源化,通过重叠PCR获得hu3D3VH的基因。构建pET22(b+)/hu3D3VH表达载体,并转化大肠杆菌BL21(DE3),在IPTG诱导下表达。表达产物通过Ni亲和层析柱纯化。采用间接ELISA和竞争抑制ELISA法进行活性分析。结果:通过重叠PCR获得序列正确的目的基因。目的蛋白以包涵体的形式表达,表达量占菌体总蛋白的30%以上。纯化后,目的蛋白的纯度达95%以上。hu3D3VH具有与亲本抗体相同的抗原反应性,并能抑制mAb3D3与L342细胞的结合。结论:获得的人源化单域抗体hu3D3VH,保留了与mAb3D3相同的反应性和特异性,为进一步临床应用奠定了基础。 AIM. To construct the gene of humanized single-domain antibody hu3D3V, against human lung cancer, to express it in E. coil and analyze its activity. METHODS: The mAb3D3VH was humanized by using CDRs grafting technique. The hu3D3VH gene was assembled by overlapping PCR. The expression vector pET22(b + )/hu3D3VH was constructed and transformed into E. coil BL21 ( DE3 ) and the hu3D3VH protein was expressed under IPTG induction. After purification by Ni2^+ -affinity chromatographic column, the activity of hu3D3VH protein was analyzed by indirect ELISA and competitive inhibition ELISA. RESULTS: The target gene with correct sequence was obtained by overlapping PCR. The hu3D3V, protein was expressed as inclusion bodies with the yield of more than 30% of total bacterial proteins. After purification, the purity of hu3D3V, was more than 95%. The reactivity of purified protein was the same as parent antibody, and could inhibit the binding of mAb3D3 to L342 cells. CONCLUSION: The hu3D3V, still retains the reactivity and specificity of mAb3D3, which lays the foundation for its further clinical application.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2006年第2期193-195,199,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 福建省自然科学基金资助项目(No.C0410004)
关键词 人源化 抗人肺癌单域抗体 表达 活性分析 humanization single-domain antibody agai-nst human lung cancer expression activityanalysis
  • 相关文献

参考文献10

二级参考文献21

  • 1Chen P P,Scand J Immunol,1990年,3期,257页
  • 2Li X,中华妇产科杂志,1997年,32卷,3期,152页
  • 3Qian H N,Chin Med J,1994年,107卷,2期,99页
  • 4Li W J,中华妇产科杂志,1994年,29卷,5期,296页
  • 5Qian H N,Gynecol Oncol,1992年,47卷,2期,216页
  • 6Qian H N,Chin Med J,1991年,104卷,2期,9页
  • 7Reiter Y, Brinkmann U, Lee B, et al. Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments[J]. Nature Biotech, 1996, 14(10): 1239-1244.
  • 8Fell HP, Gayle MA, Yelton D, et al. Chimeric L6 anti-tumor antibody[J]. J Biol Chem, 1992, 267(22): 15552-15558.
  • 9Holliger P, Prospero T, Winter G. ''Diabodies'': Small bivalent and bispecific antibody fragments[J]. Proc Natl Acad Sci USA, 1993, 90(6): 6444-6448.
  • 10Kleymann G, Ostermeier C, Heitmann K, et al. Use of antibody fragments(Fv) in immunocytochemistry[J]. J Histochem Cytochem, 1995, 43(6): 607-614.

共引文献10

同被引文献32

  • 1王栋,武国军,谭建明,王禾.人p53四价功能域对提高抗体功能性亲和力的作用[J].中华医学杂志,2005,85(7):479-482. 被引量:7
  • 2王阶平,颜江华,张长弓,王勇军,庄国洪.人源化抗人肺癌二价和四价VH单域抗体的制备及活性分析[J].中华微生物学和免疫学杂志,2007,27(2):176-179. 被引量:2
  • 3Kilinc MO, Mukundan L, Yoleu ES, et al. Generation of a multimeric form of CD40L with potent immunostimulatory activity using streptavidin as a chaperon. Exp Mol Pathol, 2006, 80 ( 3 ) : 252-261.
  • 4Dubel S, Breitling F, Kontermann B, et al. Bifunctional and multimeric complexes of streptavidin fused to single chain antibodies (scFv). J Immunol Methods, 1995, 178(2) : 201-209.
  • 5Kipriyanov SM, Little M, Kropshofer H, et al. Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion. Protein Engineering, 1996, 9(2) : 203-211.
  • 6Sambrook J,Russell DW.黄培堂,王嘉玺,朱厚础,等译.分子克隆实验指南.3版.北京:科学出版社,2002:1259-1260.
  • 7Wang WW, Das D, McQuarrie SA, et al. Design of a bifuncfional fusion protein for ovarian cancer drug delivery: Single-chain anti-CA125 core-streptavidin fusion protein. Eur J Pharm Biopharm, 2007, 65(3) : 398-405.
  • 8Xiao Z, McQuarrie SA, Suresh MR, et al. A three-step strategy for targeting drug carriers to human ovarian carcinoma cells in vivo. J Biotechnol, 2002, 94(2) : 171-184.
  • 9Forster GJ, Santos EB, Smith-Jones PM, et al. Pretargeted radioimmunothempy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal dose. J Nucl Med, 2006, 47(1) : 140-149.
  • 10Pahler A, Hendrickson WA, Kolks MAG, et al. Characterization and crystallization of core streptavidin. J Biol Chem, 1987, 262 (29) : 13933-13937.

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部